FR2613624B1 - Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines - Google Patents

Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Info

Publication number
FR2613624B1
FR2613624B1 FR8705110A FR8705110A FR2613624B1 FR 2613624 B1 FR2613624 B1 FR 2613624B1 FR 8705110 A FR8705110 A FR 8705110A FR 8705110 A FR8705110 A FR 8705110A FR 2613624 B1 FR2613624 B1 FR 2613624B1
Authority
FR
France
Prior art keywords
lactamines
reducing
effects
pharmaceutical composition
oral administrative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8705110A
Other languages
English (en)
Other versions
FR2613624A1 (fr
Inventor
Antoine Andremont
Florence Leonard
Roger Labia
Cyrille Tancrede
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Gustave Roussy (IGR)
Original Assignee
Institut Gustave Roussy (IGR)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Gustave Roussy (IGR) filed Critical Institut Gustave Roussy (IGR)
Priority to FR8705110A priority Critical patent/FR2613624B1/fr
Priority to ZA882426A priority patent/ZA882426B/xx
Priority to AU15786/88A priority patent/AU604117B2/en
Priority to PT87190A priority patent/PT87190B/pt
Priority to JP63503346A priority patent/JPH01503537A/ja
Priority to PCT/FR1988/000172 priority patent/WO1988007865A1/fr
Priority to EP88903277A priority patent/EP0309532A1/fr
Publication of FR2613624A1 publication Critical patent/FR2613624A1/fr
Priority to DK685988A priority patent/DK685988A/da
Priority to OA59487A priority patent/OA09023A/fr
Application granted granted Critical
Publication of FR2613624B1 publication Critical patent/FR2613624B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
FR8705110A 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines Expired - Fee Related FR2613624B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
ZA882426A ZA882426B (en) 1987-04-10 1988-04-07 Orally administrable therapeutic compositions for the reduction of beta-lactamines undesirable actions
PT87190A PT87190B (pt) 1987-04-10 1988-04-08 Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
JP63503346A JPH01503537A (ja) 1987-04-10 1988-04-08 β‐ラクタミン類の効果を減少させるための、経口投与可能な治療用組成物
AU15786/88A AU604117B2 (en) 1987-04-10 1988-04-08 Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
PCT/FR1988/000172 WO1988007865A1 (fr) 1987-04-10 1988-04-08 COMPOSITION PHARMACEUTIQUE, ADMINISTRABLE PAR VOIE ORALE, DESTINEE A REDUIRE LES EFFETS DES ß-LACTAMINES
EP88903277A EP0309532A1 (fr) 1987-04-10 1988-04-08 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des -lactamines
DK685988A DK685988A (da) 1987-04-10 1988-12-09 Peroralt farmaceutisk praeparat til reduktion af beta-lactaminers virkning
OA59487A OA09023A (fr) 1987-04-10 1988-12-09 Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Publications (2)

Publication Number Publication Date
FR2613624A1 FR2613624A1 (fr) 1988-10-14
FR2613624B1 true FR2613624B1 (fr) 1990-11-23

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8705110A Expired - Fee Related FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Country Status (8)

Country Link
EP (1) EP0309532A1 (fr)
JP (1) JPH01503537A (fr)
AU (1) AU604117B2 (fr)
FR (1) FR2613624B1 (fr)
OA (1) OA09023A (fr)
PT (1) PT87190B (fr)
WO (1) WO1988007865A1 (fr)
ZA (1) ZA882426B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
FR2843302B1 (fr) 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
BR112016023360B1 (pt) 2014-04-17 2023-03-07 Synthetic Biologics, Inc Beta-lactamase e seu uso
US11034966B2 (en) 2014-08-28 2021-06-15 Synthetic Biologics, Inc. E. coli-based production of beta-lactamase
JP6672277B2 (ja) 2014-10-08 2020-04-01 シンセティック・バイオロジクス・インコーポレイテッド ベータラクタマーゼ製剤およびその使用
PT3065748T (pt) 2014-12-23 2018-02-28 4D Pharma Res Ltd Uma estirpe de bacteroides thetaiotaomicron e o seu uso na redução da inflamação
US9744221B2 (en) 2014-12-23 2017-08-29 Synthetic Biologics, Inc. Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
MX2017008449A (es) 2014-12-23 2017-10-12 4D Pharma Res Ltd Polipeptido de pirina y modulacion inmune.
US20160250304A1 (en) 2015-02-23 2016-09-01 Synthetic Biologics, Inc. Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
KR20170122776A (ko) 2015-03-06 2017-11-06 신세틱 바이오로직스, 인코퍼레이티드 마이크로바이옴 보호를 위한 안전하고 유효한 베타-락타마제 투약
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
TWI733676B (zh) 2015-06-15 2021-07-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
SI3240554T1 (sl) 2015-06-15 2019-12-31 4D Pharma Research Limited, Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
BR112018010089A2 (pt) 2015-11-20 2018-11-13 4D Pharma Res Ltd composições compreendendo cepas bacterianas
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SG11201807195VA (en) 2016-03-04 2018-09-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
PT3630136T (pt) 2017-05-22 2021-06-11 4D Pharma Res Ltd Composições que compreendem estirpes bacterianas
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS60910B1 (sr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Kompozicije koje sadrže bakterijski soj roda megasphaera i njihove upotrebe
LT3638271T (lt) 2017-06-14 2021-01-11 4D Pharma Research Limited Kompozicijos, apimančios bakterines padermes

Also Published As

Publication number Publication date
PT87190A (pt) 1988-05-01
WO1988007865A1 (fr) 1988-10-20
EP0309532A1 (fr) 1989-04-05
AU604117B2 (en) 1990-12-06
FR2613624A1 (fr) 1988-10-14
AU1578688A (en) 1988-11-04
JPH01503537A (ja) 1989-11-30
OA09023A (fr) 1991-03-31
PT87190B (pt) 1992-08-31
ZA882426B (en) 1988-09-28

Similar Documents

Publication Publication Date Title
FR2613624B1 (fr) Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines
EP0302900A4 (fr) Compositions pharmaceutiques avec dissimulation du gout.
FI883785A (fi) Kapsel foer farmaceutiskt verksamt inhaleringsaemne i ett laekemedel.
NO862189D0 (no) Fremgangsmaate for overfoering av antimikrobiell virkning fra akrylforbindelser.
KR890701101A (ko) 제약학적 조성물
EP0282020A3 (en) Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
DE3852599T2 (de) Orale Zusammensetzungen.
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
FR2480603B1 (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
DE3267248D1 (en) Retard oral pharmaceutical compositions
DK585183D0 (da) 14-acyloxy-2'-halogenanthracycliner til brug som anticancer-antibiotika
GB2194733B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
MX11584A (es) Composiciones farmaceuticas
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
FR2588264B1 (fr) Composition desinfectante pour voie aerienne
EP0300036A4 (fr) Compositions pharmaceutiques a base de vasopressine.
FR2586351B1 (fr) Composition pharmaceutique a base de peroxodiphosphate pour l'inactivation d'endotoxines bacteriennes
NZ221549A (en) Penicillin derivatives & pharmaceutical compositions
FR2539994B1 (fr) Nouvelles compositions pharmaceutiques administrables par voie nasale
PT88659A (pt) Procede de preparation d'un panneau de liege agglomere en particulier pour isolation phonique et panneau obtenue par ce procede
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
FR2602680B1 (fr) Compositions pharmaceutiques pour l'administration par voie nasale
IL85093A0 (en) Pharmaceutical compositions containing retinoids for the treatment of psychotic illnesses

Legal Events

Date Code Title Description
ST Notification of lapse